Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic
December 2003
Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic.
Patients who don't take oral meds consistently can now get a shot every 2 weeks.
Risperdal Consta will come in 25, 37.5, and 50 mg vials.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote